176 related articles for article (PubMed ID: 25761590)
1. Transport of trans-tiliroside (kaempferol-3-β-D-(6"-p-coumaroyl-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine.
Luo Z; Morgan MR; Day AJ
Xenobiotica; 2015; 45(8):722-30. PubMed ID: 25761590
[TBL] [Abstract][Full Text] [Related]
2. Intestinal absorption mechanisms of prenylated flavonoids present in the heat-processed Epimedium koreanum Nakai (Yin Yanghuo).
Chen Y; Zhao YH; Jia XB; Hu M
Pharm Res; 2008 Sep; 25(9):2190-9. PubMed ID: 18459036
[TBL] [Abstract][Full Text] [Related]
3. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2.
Vaidyanathan JB; Walle T
Pharm Res; 2001 Oct; 18(10):1420-5. PubMed ID: 11697467
[TBL] [Abstract][Full Text] [Related]
4. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
5. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers.
Schutte ME; Freidig AP; van de Sandt JJ; Alink GM; Rietjens IM; Groten JP
Toxicol Appl Pharmacol; 2006 Dec; 217(2):204-15. PubMed ID: 16997339
[TBL] [Abstract][Full Text] [Related]
6. Intestinal absorption mechanisms of 2'-deoxy-2'-β-fluoro-4'-azidocytidine, a cytidine analog for AIDS treatment, and its interaction with P-glycoprotein, multidrug resistance-associated protein 2 and breast cancer resistance protein.
Liu Y; Liu B; Zhang Y; Peng Y; Huang C; Wang N; Jiang J; Wang Q; Chang J
Eur J Pharm Sci; 2017 Jul; 105():150-158. PubMed ID: 28487144
[TBL] [Abstract][Full Text] [Related]
7. MK571 inhibits phase-2 conjugation of flavonols by Caco-2/TC7 cells, but does not specifically inhibit their apical efflux.
Barrington RD; Needs PW; Williamson G; Kroon PA
Biochem Pharmacol; 2015 Jun; 95(3):193-200. PubMed ID: 25801004
[TBL] [Abstract][Full Text] [Related]
8. Multidrug resistance-associated protein 2 (MRP2) is an efflux transporter of EGCG and its metabolites in the human small intestine.
Kikuchi T; Hayashi A; Ikeda N; Morita O; Tasaki J
J Nutr Biochem; 2022 Sep; 107():109071. PubMed ID: 35636688
[TBL] [Abstract][Full Text] [Related]
9. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
[TBL] [Abstract][Full Text] [Related]
10. Studies on pharmacokinetic properties and absorption mechanism of phloretin: In vivo and in vitro.
Zhao YY; Fan Y; Wang M; Wang J; Cheng JX; Zou JB; Zhang XF; Shi YJ; Guo DY
Biomed Pharmacother; 2020 Dec; 132():110809. PubMed ID: 33049584
[TBL] [Abstract][Full Text] [Related]
11. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
12. Study on the mechanism of intestinal absorption of epimedins a, B and C in the Caco-2 cell model.
Chen Y; Wang Y; Zhou J; Gao X; Qu D; Liu C
Molecules; 2014 Jan; 19(1):686-98. PubMed ID: 24402200
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in situ study on characterization and mechanism of the intestinal absorption of 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside.
Wang C; Zhou Y; Gong X; Zheng L; Li Y
BMC Pharmacol Toxicol; 2020 Jan; 21(1):7. PubMed ID: 31969193
[TBL] [Abstract][Full Text] [Related]
14. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
[TBL] [Abstract][Full Text] [Related]
15. In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.
Zheng L; Zhu L; Zhao M; Shi J; Li Y; Yu J; Jiang H; Wu J; Tong Y; Liu Y; Hu M; Lu L; Liu Z
AAPS J; 2016 Sep; 18(5):1289-1299. PubMed ID: 27393480
[TBL] [Abstract][Full Text] [Related]
16. The bioflavonoid kaempferol is an Abcg2 substrate and inhibits Abcg2-mediated quercetin efflux.
An G; Gallegos J; Morris ME
Drug Metab Dispos; 2011 Mar; 39(3):426-32. PubMed ID: 21139040
[TBL] [Abstract][Full Text] [Related]
17. [Absorption and transport of isoflavonoid compounds from Tongmai formula across human intestinal epithelial (Caco-2) cells in vitro].
Wang FR; Yang XW
Zhongguo Zhong Yao Za Zhi; 2017 Aug; 42(16):3206-3212. PubMed ID: 29171242
[TBL] [Abstract][Full Text] [Related]
18. A new mechanism for increasing the oral bioavailability of scutellarin with Cremophor EL: Activation of MRP3 with concurrent inhibition of MRP2 and BCRP.
Xiao L; Yi T; Chen M; Lam CW; Zhou H
Eur J Pharm Sci; 2016 Oct; 93():456-67. PubMed ID: 27586020
[TBL] [Abstract][Full Text] [Related]
19. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
20. Kaempferol suppression of acute colitis is regulated by the efflux transporters BCRP and MRP2.
Liu Y; Lu Y; Li X; Zhang Z; Sun L; Wang Y; He Z; Liu Z; Zhu L; Fu L
Eur J Pharm Sci; 2022 Dec; 179():106303. PubMed ID: 36252521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
